{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:34:10Z","timestamp":1762004050077},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.urology.2007.09.008","type":"journal-article","created":{"date-parts":[[2007,12,28]],"date-time":"2007-12-28T10:51:33Z","timestamp":1198839093000},"page":"1222.e13-1222.e16","source":"Crossref","is-referenced-by-count":18,"title":["Primary Malignant Melanoma of the Female Urethra"],"prefix":"10.1016","volume":"70","author":[{"given":"Tsuyoshi","family":"Yoshizawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomu","family":"Kawata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Hirakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taketo","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenya","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2007.09.008_bib1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/1097-0142(19930115)71:2<448::AID-CNCR2820710227>3.0.CO;2-Y","article-title":"Primary malignant melanoma of the female urethra","volume":"71","author":"Kim","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2007.09.008_bib2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/00000478-200006000-00003","article-title":"Primary malignant melanoma of the urethra: a clinicopathologic analysis of 15 cases","volume":"24","author":"Oliva","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urology.2007.09.008_bib3","first-page":"381","article-title":"5 years experience of 5-S-cysteinyldopa in melanoma diagnosis","volume":"59","author":"Agrup","year":"1979","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.urology.2007.09.008_bib4","first-page":"73","article-title":"Clinical study of DAV + IFN\u03b2 therapy for malignant melanoma","volume":"7","author":"Yamamoto","year":"1996","journal-title":"Int J Immunother"},{"key":"10.1016\/j.urology.2007.09.008_bib5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/0090-4295(87)90055-0","article-title":"Malignant melanomas of female urethra","volume":"24","author":"Nissenkorn","year":"1987","journal-title":"Urology"},{"key":"10.1016\/j.urology.2007.09.008_bib6","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/01.ju.0000104671.20863.47","article-title":"Outcome of surgical treatment for primary malignant melanoma of the female urethra","volume":"171","author":"DiMarco","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2007.09.008_bib7","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1097\/00006534-200004050-00028","article-title":"Current therapy of cutaneous melanoma","volume":"105","author":"Wagner","year":"2000","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.urology.2007.09.008_bib8","first-page":"744","article-title":"Systemic chemotherapy for the treatment of metastatic melanoma","volume":"23","author":"McClay","year":"1996","journal-title":"Semin Oncol"},{"key":"10.1016\/j.urology.2007.09.008_bib9","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1200\/JCO.2005.05.2498","article-title":"Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responses","volume":"24","author":"Moschos","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2007.09.008_bib10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/sj.bjc.6603291","article-title":"Sorafenib in advanced melanoma: a phase II randomised discontinuation trial analysis","volume":"95","author":"Eisen","year":"2006","journal-title":"Br J Cancer"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429507021334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429507021334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T19:54:27Z","timestamp":1546372467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429507021334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0090429507021334"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2007.09.008","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}